The evanescence and persistence of RBC alloantibodies in blood donors
- 15 February 2020
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 60 (4), 831-839
- https://doi.org/10.1111/trf.15718
Abstract
BACKGROUND Blood donors represent a healthy population, whose red blood cell (RBC) alloantibody persistence or evanescence kinetics may differ from those of immunocompromised patients. A better understanding of the biologic factors impacting antibody persistence is warranted, as the presence of alloantibodies may impact donor health and the fate of the donated blood product. METHODS Donor/donation data collected from four US blood centers from 2012 to 2016 as part of the Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III) were analyzed. Clinically significant antibodies from blood donors with more than one donation who underwent at least one follow‐up antibody screen after the initial antibody identification were included. Of 632,378 blood donors, 481 (128 males and 353 females) fit inclusion criteria. RESULTS Antibody screens detected 562 alloantibodies, with 368 of 562 (65%) of antibodies being persistently detected and with 194 of 562 (35%) becoming evanescent. Factors associated with antibody persistence included antibody specificity, detection at the first donation, reported history of transfusion, and detection of multiple antibodies concurrently. Anti‐D, C, and Fya were most likely to persist, while anti‐M, Jka, and S were most frequently evanescent. CONCLUSIONS These data provide insight into variables impacting the duration of antibody detection, and they may also influence blood donor center policies regarding donor recruitment/acceptance.Keywords
This publication has 19 references indexed in Scilit:
- Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusionsBritish Journal of Haematology, 2014
- Red Blood Cell Alloimmunization Mitigation StrategiesTransfusion Medicine Reviews, 2014
- Should blood donors be routinely screened for irregular antibodies?Immunohematology, 2012
- IMMUNOHEMATOLOGY: The characterization and classification of concurrent blood group antibodiesTransfusion, 2009
- Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodiesBlood, 2009
- The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion‐related acute lung injury risk reduction strategyTransfusion, 2009
- The persistence and evanescence of blood group alloantibodies in menTransfusion, 2009
- RBC antibody persistenceTransfusion, 2000
- Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal DistributionsJournal of the American Statistical Association, 1989
- Incidence of Antibodies Occurring in Healthy Donor SeraTransfusion, 1965